Error: Could not add to watchlist. X
+ Watchlist

Axcan Pharma Inc

AXCA:US
Acquired
AXCA:US was acquired by 1358551D:CN
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Axcan Pharma Inc. operates as a pharmaceutical company. The Company researches, develops, and distributes pharmaceutical products for the treatment of gastrointestinal diseases and disorders, including inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases, and complications related to cystic fibrosis.
Address
597 Laurier Blvd
Mont-Saint-Hilaire, QC J3H 6C4
Canada
Phone
1-450-467-5138